Determinants of self-efficacy in patients with Parkinson’s disease

ABSTRACT Background: Self-efficacy is the individual’s assessment of his or hers ability to complete a specific task successfully and has been closely related self-management quality life in several diseases. Objective: To investigate self-efficacy population Parkinson’s disease (PD) patients Mexico study factors that are associated with this measure. Methods: We carried out cross-sectional observational involving PD an outpatient neurology clinic Mexico, using following instruments: Spanish version Chronic Disease Self-Efficacy Scale (CDSES), Quality Life Questionnaire PDQ-8, Movement Disorders Society-Unified Parkinson's Rating (MDS-UPDRS), Montreal Cognitive Assessment (MoCA), Non-Motor Symptom (NMSS). Clinical demographic variables were also recorded. Results: included 73 mean age 65 years most male. Patients lower CDSES scores (<7.75) had worse MDS-UPDRS, NMSS, PDQ-8 scales. significantly correlated MDS-UPDRS Part I (r=-0.497, p=<0.001), II (r= -0.271, p=0.020), III (r=-0.304, (r=-0.472, NMSS (r=-0.504, p=<0.001). Furthermore, when assessing simultaneous effect covariates score, only Mood/Apathy domain was significant (beta= -0.446, t= -3.807, p= 0.012). Conclusions: motor non-motor symptomatology life. disorders negatively contributed